OUR EXPERTS

Nonclinical Safety

Meet some of the renowned scientists, physicians, and engineers who help BlueRidge clients achieve their most important life science goals.

Swipe to learn more about our experts

  • Kristina Ulrich, PhD, ERT

    SENIOR MANAGING SCIENTIST, DIRECTOR, NONCLINICAL TOXICOLOGY
    ToxStrategies

    I specialize in the design and implementation of nonclinical safety strategies to facilitate the advancement of novel therapeutics into clinical development and beyond. I have 20+ years of experience as a toxicologist/drug developer from a number of large pharmaceutical companies, as well being a former non-clinical assessor at MHRA. I leverage this expertise to enable my clients to make informed decisions about their safety challenges and to support streamlined progression of their programs.

  • Marcie Wood, PhD

    PRINCIPAL SCIENTIST, SENIOR VICE PRESIDENT, NONCLINICAL TOXICOLOGY
    ToxStrategies

    My expertise includes developing nonclinical toxicology program technical and regulatory strategies to support advancement of therapeutic products into clinical trials and beyond. I have 20+ years of experience as a toxicologist, drug development professional, and former FDA leader, and I leverage this background to support clients with nonclinical challenges at all stages of drug development.